Home›Companies›Biotech & Pharma›Revalia Bio

Revalia Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 6, 2024·Suggest an edit

About Revalia Bio

Revalia Bio is a private company based in New Haven, Connecticut, incorporated in 2021 in Delaware. It has reported $12,294,616 raised in one offering on Form D since November 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 25, 2024Nov 6, 2024$12,294,616of $16.9M target32$384KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Revalia Bio's Form D filed Nov 6, 2024.

MA
BW
GT
Gregory Tietjen
President and director

Sources

  1. SECRevalia Bio, Inc. filing history